CAPTOR THHERAP. ZY-10

Research CAPTOR THHERAP. ZY-10 (60Q) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

• Ticker60Q
• ExchangeF
• CountryPoland
• CurrencyEUR
• Financial periodFY2022
• RevenuePLN 9.16M
• Revenue growth129.8%
• Net income-PLN 35.89M
• Gross margin77.2%

About CAPTOR THHERAP. ZY-10

General Information 1. The information on the Capital Group Captor Therapeutics S.A. (the "Company", "Entity", "Dominant Entity", or "Issuer") was entered into the Polish National Court Register on December 30, 2015, as a limited liability company under number KRS 0000594615, and subsequently transformed into an SA. The transformation of Captor Therapeutics Sp. z o.o. into Captor Therapeutics S.A.

Frequently asked questions

What does CAPTOR THHERAP. ZY-10 do?

General Information 1. The information on the Capital Group Captor Therapeutics S.A. (the "Company", "Entity", "Dominant Entity", or "Issuer") was entered into the Polish National Court Register on December 30, 2015, as a limited liability company under number KRS 0000594615, and subsequently...